State Of Wyoming Aligos Therapeutics, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.08 - $12.2 $230 - $1,354	-111 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$11.48 - $17.69 $229 - $353	20 Added 21.98%	111 $1,000
Q3 2021 Feb 11, 2022	SELL	$14.57 - $17.72 $641 - $779	-44 Reduced 32.59%	91 $1,000
Q2 2021 Feb 11, 2022	BUY	$20.3 - $33.6 $1,441 - $2,385	71 Added 110.94%	135 $3,000
Q1 2021 Feb 08, 2022	BUY	$19.1 - $34.94 $1,222 - $2,236	64 New	64 $1,000

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.28B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.